The pharmaceutical world is witnessing a significant shift in diabetes treatment with the emergence of GLP-1 transdermal devices. These systems offer a potentially more user-friendly alternative to subcutaneous https://jimirrr309863.activosblog.com/39558342/glp-1-patches-a-new-approach-to-diabetes-care